Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fear | 62 | 2019 | 272 | 12.130 |
Why?
|
| Extinction, Psychological | 54 | 2019 | 104 | 10.680 |
Why?
|
| Prefrontal Cortex | 42 | 2022 | 164 | 8.790 |
Why?
|
| Amygdala | 31 | 2020 | 125 | 4.810 |
Why?
|
| Avoidance Learning | 13 | 2024 | 70 | 4.430 |
Why?
|
| Conditioning, Classical | 22 | 2016 | 67 | 3.600 |
Why?
|
| Memory | 19 | 2015 | 174 | 3.380 |
Why?
|
| Neurons | 27 | 2019 | 1263 | 2.530 |
Why?
|
| Rats | 58 | 2024 | 3735 | 2.490 |
Why?
|
| Obsessive-Compulsive Disorder | 7 | 2024 | 25 | 2.160 |
Why?
|
| Rats, Sprague-Dawley | 43 | 2024 | 1766 | 2.090 |
Why?
|
| Neurosciences | 7 | 2024 | 34 | 2.090 |
Why?
|
| Hippocampus | 11 | 2018 | 594 | 1.760 |
Why?
|
| Animals | 84 | 2024 | 16992 | 1.680 |
Why?
|
| Limbic System | 7 | 2018 | 31 | 1.570 |
Why?
|
| Neural Pathways | 17 | 2024 | 138 | 1.550 |
Why?
|
| Mental Recall | 10 | 2012 | 84 | 1.540 |
Why?
|
| Conditioning, Operant | 11 | 2016 | 90 | 1.490 |
Why?
|
| Cerebral Cortex | 8 | 2022 | 306 | 1.410 |
Why?
|
| Brain-Derived Neurotrophic Factor | 4 | 2018 | 81 | 1.350 |
Why?
|
| Anxiety Disorders | 7 | 2017 | 322 | 1.300 |
Why?
|
| Implosive Therapy | 3 | 2020 | 14 | 1.230 |
Why?
|
| Neuronal Plasticity | 9 | 2018 | 126 | 1.220 |
Why?
|
| Action Potentials | 17 | 2019 | 246 | 1.190 |
Why?
|
| Behavior, Animal | 17 | 2024 | 373 | 1.150 |
Why?
|
| Brain Mapping | 9 | 2016 | 137 | 1.120 |
Why?
|
| Nerve Net | 5 | 2020 | 101 | 1.020 |
Why?
|
| Rodentia | 3 | 2022 | 47 | 1.010 |
Why?
|
| Male | 60 | 2024 | 23409 | 0.960 |
Why?
|
| Brain | 9 | 2024 | 1472 | 0.910 |
Why?
|
| Neural Inhibition | 4 | 2018 | 48 | 0.910 |
Why?
|
| Association Learning | 7 | 2010 | 35 | 0.840 |
Why?
|
| Yohimbine | 3 | 2009 | 24 | 0.830 |
Why?
|
| Adrenergic alpha-Antagonists | 3 | 2009 | 29 | 0.820 |
Why?
|
| Mentors | 1 | 2024 | 145 | 0.790 |
Why?
|
| Proto-Oncogene Proteins c-fos | 5 | 2018 | 83 | 0.780 |
Why?
|
| Time Factors | 15 | 2015 | 1857 | 0.750 |
Why?
|
| Deep Brain Stimulation | 4 | 2016 | 17 | 0.720 |
Why?
|
| Corpus Striatum | 3 | 2020 | 121 | 0.710 |
Why?
|
| Signal Transduction | 4 | 2018 | 2157 | 0.710 |
Why?
|
| Thalamus | 4 | 2020 | 34 | 0.700 |
Why?
|
| Research | 4 | 2019 | 181 | 0.690 |
Why?
|
| Sucrose | 2 | 2017 | 33 | 0.610 |
Why?
|
| Analysis of Variance | 10 | 2015 | 575 | 0.610 |
Why?
|
| Cues | 4 | 2017 | 81 | 0.610 |
Why?
|
| Reward | 3 | 2020 | 112 | 0.610 |
Why?
|
| Nucleus Accumbens | 2 | 2017 | 100 | 0.600 |
Why?
|
| Acoustic Stimulation | 12 | 2015 | 78 | 0.540 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 1596 | 0.530 |
Why?
|
| Biomedical Research | 3 | 2021 | 502 | 0.520 |
Why?
|
| Developing Countries | 4 | 1999 | 113 | 0.490 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2024 | 587 | 0.490 |
Why?
|
| Learning | 4 | 2007 | 161 | 0.490 |
Why?
|
| Cognition | 5 | 2024 | 473 | 0.490 |
Why?
|
| Humans | 42 | 2024 | 43102 | 0.480 |
Why?
|
| Minority Groups | 2 | 2021 | 690 | 0.470 |
Why?
|
| Muscimol | 5 | 2016 | 16 | 0.450 |
Why?
|
| Gyrus Cinguli | 5 | 2022 | 31 | 0.430 |
Why?
|
| Amphetamine | 2 | 2014 | 21 | 0.410 |
Why?
|
| Electroshock | 6 | 2012 | 15 | 0.390 |
Why?
|
| Appetitive Behavior | 1 | 2013 | 16 | 0.390 |
Why?
|
| Sensory Gating | 1 | 2012 | 5 | 0.390 |
Why?
|
| Ethanol | 1 | 2015 | 224 | 0.380 |
Why?
|
| Stress Disorders, Post-Traumatic | 6 | 2019 | 568 | 0.380 |
Why?
|
| Basal Ganglia | 1 | 2012 | 21 | 0.370 |
Why?
|
| Propranolol | 2 | 2009 | 18 | 0.370 |
Why?
|
| Midline Thalamic Nuclei | 1 | 2011 | 1 | 0.360 |
Why?
|
| Central Nervous System Stimulants | 2 | 2014 | 180 | 0.350 |
Why?
|
| Emotions | 3 | 2006 | 254 | 0.350 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2010 | 35 | 0.330 |
Why?
|
| Puerto Rico | 4 | 2019 | 1413 | 0.330 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2010 | 135 | 0.320 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2010 | 83 | 0.320 |
Why?
|
| Social Behavior | 2 | 2024 | 161 | 0.310 |
Why?
|
| Anxiety | 6 | 2024 | 874 | 0.310 |
Why?
|
| Freezing Reaction, Cataleptic | 4 | 2019 | 13 | 0.300 |
Why?
|
| Mesencephalon | 1 | 2009 | 49 | 0.290 |
Why?
|
| Substance-Related Disorders | 2 | 2009 | 830 | 0.280 |
Why?
|
| Schizophrenia | 1 | 2009 | 93 | 0.280 |
Why?
|
| Norepinephrine | 1 | 2008 | 97 | 0.270 |
Why?
|
| Locomotion | 3 | 2024 | 105 | 0.270 |
Why?
|
| Entorhinal Cortex | 1 | 2006 | 11 | 0.250 |
Why?
|
| Electric Stimulation | 9 | 2016 | 186 | 0.250 |
Why?
|
| Safety | 1 | 2007 | 54 | 0.250 |
Why?
|
| Nutrition Disorders | 2 | 1998 | 12 | 0.250 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 53 | 0.230 |
Why?
|
| Models, Neurological | 3 | 2013 | 136 | 0.230 |
Why?
|
| Motor Activity | 4 | 2014 | 437 | 0.230 |
Why?
|
| Toluene | 1 | 2024 | 11 | 0.220 |
Why?
|
| Honduras | 4 | 2017 | 8 | 0.220 |
Why?
|
| Memory Disorders | 1 | 2005 | 77 | 0.220 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 2 | 2017 | 25 | 0.220 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2004 | 20 | 0.220 |
Why?
|
| Auditory Cortex | 3 | 1998 | 15 | 0.200 |
Why?
|
| Cell Nucleus | 1 | 2005 | 383 | 0.200 |
Why?
|
| Excitatory Amino Acid Antagonists | 3 | 2010 | 92 | 0.190 |
Why?
|
| Affect | 2 | 2016 | 180 | 0.180 |
Why?
|
| Piperazines | 3 | 2010 | 120 | 0.180 |
Why?
|
| Compulsive Behavior | 1 | 2022 | 31 | 0.180 |
Why?
|
| N-Methylaspartate | 1 | 2001 | 59 | 0.180 |
Why?
|
| Cats | 3 | 2007 | 82 | 0.180 |
Why?
|
| Galvanic Skin Response | 4 | 2014 | 17 | 0.170 |
Why?
|
| Recombinant Proteins | 2 | 2014 | 518 | 0.170 |
Why?
|
| Neurophysiology | 2 | 1997 | 10 | 0.160 |
Why?
|
| Motor Cortex | 4 | 1995 | 54 | 0.160 |
Why?
|
| Journalism, Medical | 1 | 2019 | 5 | 0.160 |
Why?
|
| Information Dissemination | 1 | 2019 | 66 | 0.150 |
Why?
|
| Injections, Intraperitoneal | 2 | 2009 | 60 | 0.150 |
Why?
|
| Corticosterone | 1 | 2019 | 90 | 0.150 |
Why?
|
| Reaction Time | 6 | 2013 | 157 | 0.150 |
Why?
|
| Pyramidal Tracts | 3 | 1995 | 35 | 0.140 |
Why?
|
| Behavior Therapy | 2 | 2010 | 180 | 0.140 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 1998 | 9 | 0.140 |
Why?
|
| Growth Disorders | 1 | 1998 | 23 | 0.140 |
Why?
|
| Communication | 1 | 2019 | 210 | 0.130 |
Why?
|
| Brain Ischemia | 1 | 2019 | 189 | 0.130 |
Why?
|
| Astrocytes | 1 | 2019 | 244 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 719 | 0.130 |
Why?
|
| Macaca | 2 | 2016 | 36 | 0.130 |
Why?
|
| Sex Factors | 2 | 2024 | 1028 | 0.130 |
Why?
|
| Evoked Potentials | 4 | 2006 | 91 | 0.130 |
Why?
|
| Central Nervous System | 1 | 1998 | 152 | 0.130 |
Why?
|
| Internal Capsule | 1 | 2016 | 3 | 0.120 |
Why?
|
| Microinjections | 1 | 2016 | 50 | 0.120 |
Why?
|
| Laboratories | 1 | 1995 | 40 | 0.120 |
Why?
|
| Morphine | 1 | 2016 | 69 | 0.120 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2015 | 98 | 0.120 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 153 | 0.110 |
Why?
|
| Torture | 1 | 1994 | 1 | 0.110 |
Why?
|
| Massachusetts | 1 | 2014 | 35 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 1124 | 0.110 |
Why?
|
| Electrodes, Implanted | 3 | 2004 | 22 | 0.110 |
Why?
|
| Reinforcement Schedule | 2 | 2004 | 15 | 0.110 |
Why?
|
| Politics | 1 | 1994 | 42 | 0.110 |
Why?
|
| Synaptic Transmission | 1 | 1995 | 149 | 0.100 |
Why?
|
| Glutamic Acid | 1 | 2015 | 131 | 0.100 |
Why?
|
| Female | 12 | 2024 | 24698 | 0.100 |
Why?
|
| Antibodies | 1 | 2014 | 144 | 0.100 |
Why?
|
| Long-Term Potentiation | 2 | 2006 | 109 | 0.100 |
Why?
|
| Violence | 1 | 1994 | 136 | 0.100 |
Why?
|
| Family | 1 | 1994 | 195 | 0.100 |
Why?
|
| Auditory Perception | 1 | 2014 | 70 | 0.100 |
Why?
|
| Educational Status | 1 | 2014 | 339 | 0.100 |
Why?
|
| Mental Disorders | 2 | 2009 | 392 | 0.100 |
Why?
|
| Electrophysiology | 5 | 2008 | 138 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 113 | 0.090 |
Why?
|
| Polymorphism, Genetic | 1 | 2013 | 201 | 0.090 |
Why?
|
| Oncogene Proteins v-fos | 1 | 2011 | 4 | 0.090 |
Why?
|
| GABA Agonists | 1 | 2011 | 21 | 0.090 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 93 | 0.090 |
Why?
|
| Age Factors | 1 | 2014 | 1154 | 0.090 |
Why?
|
| Species Specificity | 2 | 2016 | 286 | 0.090 |
Why?
|
| Raclopride | 1 | 2010 | 8 | 0.090 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 2676 | 0.080 |
Why?
|
| Dopamine Antagonists | 1 | 2010 | 48 | 0.080 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2010 | 26 | 0.080 |
Why?
|
| Darkness | 1 | 1990 | 28 | 0.080 |
Why?
|
| Behavior | 1 | 2010 | 35 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 934 | 0.080 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2009 | 39 | 0.080 |
Why?
|
| Mice | 3 | 2019 | 6644 | 0.080 |
Why?
|
| Models, Psychological | 1 | 2010 | 140 | 0.080 |
Why?
|
| Photic Stimulation | 1 | 2010 | 125 | 0.080 |
Why?
|
| Sotalol | 1 | 2009 | 1 | 0.080 |
Why?
|
| Adult | 8 | 2024 | 13872 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2009 | 123 | 0.070 |
Why?
|
| Thionucleotides | 1 | 2008 | 8 | 0.070 |
Why?
|
| Pyramidal Cells | 1 | 2008 | 65 | 0.070 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2008 | 54 | 0.070 |
Why?
|
| Expressed Emotion | 1 | 2007 | 9 | 0.070 |
Why?
|
| Heart Rate | 1 | 2009 | 266 | 0.070 |
Why?
|
| Psychiatry | 1 | 2007 | 36 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2008 | 150 | 0.070 |
Why?
|
| Synapses | 1 | 2008 | 185 | 0.070 |
Why?
|
| Cyclic AMP | 1 | 2008 | 127 | 0.070 |
Why?
|
| Tetrodotoxin | 1 | 2006 | 22 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2008 | 352 | 0.060 |
Why?
|
| Anesthetics, Local | 1 | 2006 | 20 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 159 | 0.060 |
Why?
|
| Radionuclide Imaging | 1 | 2006 | 29 | 0.060 |
Why?
|
| Models, Animal | 1 | 2006 | 151 | 0.060 |
Why?
|
| United States | 1 | 2017 | 5205 | 0.060 |
Why?
|
| Snails | 1 | 2005 | 32 | 0.060 |
Why?
|
| Administration, Inhalation | 1 | 2024 | 92 | 0.050 |
Why?
|
| Anisomycin | 1 | 2004 | 8 | 0.050 |
Why?
|
| Injections, Intraventricular | 1 | 2004 | 59 | 0.050 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2004 | 43 | 0.050 |
Why?
|
| Harm Reduction | 1 | 2024 | 27 | 0.050 |
Why?
|
| Microelectrodes | 1 | 2003 | 22 | 0.050 |
Why?
|
| Brain Stem | 1 | 2003 | 52 | 0.050 |
Why?
|
| Sound | 1 | 2002 | 8 | 0.050 |
Why?
|
| Latin America | 1 | 2022 | 55 | 0.050 |
Why?
|
| Panic Disorder | 1 | 2003 | 102 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2019 | 1604 | 0.050 |
Why?
|
| Young Adult | 2 | 2024 | 5080 | 0.040 |
Why?
|
| Maryland | 1 | 2021 | 66 | 0.040 |
Why?
|
| Habits | 1 | 2020 | 8 | 0.040 |
Why?
|
| Denervation | 1 | 2000 | 27 | 0.040 |
Why?
|
| Neural Conduction | 2 | 1998 | 17 | 0.040 |
Why?
|
| Dependovirus | 1 | 2019 | 18 | 0.040 |
Why?
|
| Public Opinion | 1 | 1999 | 20 | 0.040 |
Why?
|
| Cerebellum | 1 | 2019 | 79 | 0.040 |
Why?
|
| Research Personnel | 1 | 2021 | 206 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2000 | 284 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2000 | 159 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2013 | 490 | 0.040 |
Why?
|
| Nerve Degeneration | 1 | 2019 | 111 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 2 | 2010 | 228 | 0.040 |
Why?
|
| Neuroglia | 1 | 2019 | 133 | 0.040 |
Why?
|
| Child | 2 | 1998 | 3443 | 0.030 |
Why?
|
| Spinal Cord | 2 | 1990 | 114 | 0.030 |
Why?
|
| Forecasting | 1 | 1998 | 136 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 665 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1285 | 0.030 |
Why?
|
| Neuroanatomical Tract-Tracing Techniques | 1 | 2016 | 1 | 0.030 |
Why?
|
| Equipment and Supplies | 1 | 1995 | 10 | 0.030 |
Why?
|
| Social Problems | 1 | 1995 | 14 | 0.030 |
Why?
|
| Oxygen | 2 | 2007 | 218 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2007 | 174 | 0.030 |
Why?
|
| Computers | 1 | 1995 | 35 | 0.030 |
Why?
|
| Budgets | 1 | 1995 | 15 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 1995 | 32 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1063 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 1995 | 61 | 0.030 |
Why?
|
| Teaching | 1 | 1995 | 59 | 0.030 |
Why?
|
| Wheat Germ Agglutinins | 1 | 2015 | 8 | 0.030 |
Why?
|
| Bereavement | 1 | 1994 | 8 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 1995 | 55 | 0.030 |
Why?
|
| Grief | 1 | 1994 | 7 | 0.030 |
Why?
|
| Personality Assessment | 1 | 1994 | 45 | 0.030 |
Why?
|
| Program Development | 1 | 1995 | 240 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 1995 | 283 | 0.030 |
Why?
|
| Schools, Medical | 1 | 1995 | 208 | 0.030 |
Why?
|
| Students, Medical | 1 | 1995 | 158 | 0.030 |
Why?
|
| Cohort Studies | 1 | 1998 | 1759 | 0.020 |
Why?
|
| Trauma Severity Indices | 1 | 2013 | 31 | 0.020 |
Why?
|
| Methionine | 1 | 2013 | 27 | 0.020 |
Why?
|
| Curriculum | 1 | 1995 | 318 | 0.020 |
Why?
|
| Valine | 1 | 2013 | 29 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 17 | 0.020 |
Why?
|
| Rest | 1 | 2012 | 32 | 0.020 |
Why?
|
| Television | 1 | 1992 | 27 | 0.020 |
Why?
|
| Urethane | 1 | 1992 | 4 | 0.020 |
Why?
|
| Anesthesia | 1 | 1992 | 16 | 0.020 |
Why?
|
| Theta Rhythm | 1 | 1992 | 11 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 440 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 1994 | 420 | 0.020 |
Why?
|
| Magnetics | 1 | 1990 | 43 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2010 | 101 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 800 | 0.020 |
Why?
|
| Light | 1 | 1990 | 185 | 0.020 |
Why?
|
| Space Perception | 1 | 1987 | 35 | 0.020 |
Why?
|
| Psychophysics | 1 | 2007 | 13 | 0.020 |
Why?
|
| Rats, Inbred Strains | 3 | 1992 | 126 | 0.010 |
Why?
|
| Adolescent | 1 | 1994 | 6081 | 0.010 |
Why?
|
| Efferent Pathways | 2 | 1990 | 16 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 12222 | 0.010 |
Why?
|
| Walking | 1 | 1992 | 88 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1990 | 139 | 0.000 |
Why?
|
| Naloxone | 1 | 1987 | 56 | 0.000 |
Why?
|
| Scalp | 1 | 1987 | 12 | 0.000 |
Why?
|
| Muscles | 1 | 1987 | 82 | 0.000 |
Why?
|
| Interneurons | 1 | 1987 | 65 | 0.000 |
Why?
|
| Motor Neurons | 1 | 1987 | 90 | 0.000 |
Why?
|